Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“POR is located in the endoplasmic reticulum of the cells, where it operates as an electron donor for the cytochromes P450, heme oxygenase, squalene monooxygenase, and other redox partners [2,3,4].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [3]
In the citing paper
“PORD manifests with a wide range of clinical signs and symptoms, and our study shows a broader phenotypic expression in Caucasian patients than previously observed in a large Japanese cohort (3, 7, 14, 15).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“We previously demonstrated predominant 17α-hydroxylase over 21-hydroxylase impairment by p.A287P (21), and indeed, arterial hypertension has been documented in homozygous carriers (3, 12), probably caused by excess deoxycorticosterone production as in classical 17α-hydroxylase deficiency.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“Before our study only two p.A287P homozygous patients have been described; one with an unclear karyotype and genital appearance (7) and the other with ambiguous genitalia and 46,XY DSD (3).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“Of note, the clinical presentation of PORD shows broad phenotypic variability, with adrenal insufficiency, DSD, and skeletal malformations present in some patients but not in others (3, 7, 15, 17).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
24 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationThe genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citationShen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
Self-citationGeller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183
Self-citationPeterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Reardon, W., Smith, A., Honour, J. W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Adès, L., Sillence, D., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.26 · Cited by 123
Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia
Kelley, R. I., Kratz, L. E., Glaser, R. L., Netzloff, M. L., Miller Wolf, L., & Jabs, E. W. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10510 · Cited by 95
Self-citation
Research works printed but not linked: 2
- Miller, W.L. N. Engl. J. Med. 314, 1321–1322 (1986).
- Auchus, R.J. & Miller, W.L. Mol. Endocrinol. 13, 1169–1182 (1999).
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“In recent years rare POR missense mutations in humans were discovered that cause disordered steroidogenesis, ambiguous genitalia, and Antley–Bixler syndrome (Flück et al., 2004; Huang et al., 2005; Flück et al., 2008).”
BackgroundThe Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationYan, B., Ai, Y., Sun, Q., Ma, Y., Cao, Y., Wang, J., Zhang, Z., & Wang, X. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.11.024 · Cited by 617
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
“Human POR deficiency causes dysregulated steroidogenesis and the Antley–Bixler skeletal malformation syndrome, whereas clinically apparent disorders of drug metabolism are rare [22–24].”
BackgroundSelf-citationMalformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Disorders of sex development: a new definition and classification
Hughes, I. A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.11.001 · Cited by 438
Krone, N., Hughes, B. A., Lavery, G. G., Stewart, P. M., Arlt, W., & Shackleton, C. H. L. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.04.010 · Cited by 434
Self-citationSteroidogenesis in the Fetal Testis and Its Susceptibility to Disruption by Exogenous Compounds
Scott, H. M., Mason, J. I., & Sharpe, R. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0016 · Cited by 350
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
“R457H was also found on 1 of 2 Jap- Huang et al.: P450 Oxidoreductase Deficiency 739 anese alleles in our initial study (Flück et al. 2004) and on 2 of 4 alleles (Adachi et al. 2004) and 10 of 16 alleles (Fukami et al. 2005) in two recent studies of Japanese patients.”
BackgroundMethodResultInfluentialSelf-citationThe backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationGenetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Self-citationIyanagi, T. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(06)60002-8 · Cited by 290
A Genetic-Pathophysiological Framework for Craniosynostosis
Twigg, S. R. F., & Wilkie, A. O. M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.006 · Cited by 276
“Recessive mutations in POR (MIM: 124015), the flavoprotein that donates electrons to all microsomal P450 enzymes, cause Antley-Bixler syndrome (MIM: 201750), in which craniosynostosis is associated with abnormal steroidogenesis.(43) A genotype-phenotype correlation is apparent, such that individuals with skeletal malf…”
BackgroundNADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Self-citationFlück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Self-citationNeonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
“During stimulation testing, clinicians should keep in mind that 17-OHP levels might be elevated as a result of other enzymatic defects, particularly 11β-hydroxylase deficiency and, more rarely, 3β-hydroxysteroid dehydrogenase deficiency and P450 oxidoreductase deficiency (Antley–Bixler syndrome)”
Steroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226
Self-citationSteroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
“Additional clues to PORD include elevated 17OHP and 21-deoxycortisol as in 21- hydroxylase deficiency, the presence of Antley-Bixler syndrome malformations in some but not all cases, and maternal virilization during pregnancy.”
InfluentialPharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
Klein, K., & Zanger, U. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00012 · Cited by 220
“In recent years rare POR missense mutations in humans were discovered that impair POR function and cause disordered steroidogenesis, ambiguous genitalia, and Antley–Bixler syndrome (Flück et al., 2004; Flück and Pandey, 2011).”
BackgroundBasic concepts and recent developments in human steroid hormone biosynthesis
Ghayee, H. K., & Auchus, R. J. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9052-2 · Cited by 212
“The molecular basis of this disorder was elucidated in 2003 and found to be incomplete loss of POR activity [51].”
Background46,XY disorders of sex development (DSD)
Mendonca, B. B., Domenice, S., Arnhold, I. J. P., & Costa, E. M. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03392.x · Cited by 204
Huang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198
“In comparing the capacity of POR mutants to reduce cytochrome c, oxidize NADPH, and support the two activities of P450c17, we identified substantial, but highly reproducible differences in the activity revealed by these four assays (5, 8).”
BackgroundResultInfluentialSelf-citationLorbek, G., Lewinska, M., & Rozman, D. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08432.x · Cited by 196
Perry, R., Kecha, O., Paquette, J., Huot, C., Van Vliet, G., & Deal, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0016 · Cited by 194
“Diagnoses not represented in our series include mutations in the gene for steroidogenic factor-1, or SF1 (38), IMAGe syndrome (intrauterine growth retardation/metaphysial dysplasia/adrenal hypoplasia/genital anomalies) (39), SmithLemli-Opitz syndrome (40, 41), and Antley-Bixler syndrome (42, 43).”
BackgroundLaue, K., Pogoda, H.-M., Daniel, P. B., van Haeringen, A., Alanay, Y., von Ameln, S., Rachwalski, M., Morgan, T., Gray, M. J., Breuning, M. H., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.015 · Cited by 188
Šrejber, M., Navrátilová, V., Paloncýová, M., Bazgier, V., Berka, K., Anzenbacher, P., & Otyepka, M. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.03.002 · Cited by 190
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Self-citationRegulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165
Self-citationGenetics of Craniosynostosis: Genes, Syndromes, Mutations and Genotype-Phenotype Correlations
Passos-Bueno, M. R., Sertié, A. L., Jehee, F. S., Fanganiello, R., & Yeh, E. (2008) · Frontiers of Oral Biology · doi:10.1159/000115035 · Cited by 164
Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
Wei, W., Schwaid, A. G., Wang, X., Wang, X., Chen, S., Chu, Q., Saghatelian, A., & Wan, Y. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.010 · Cited by 161
Redox Partners: Function Modulators of Bacterial P450 Enzymes
Li, S., Du, L., & Bernhardt, R. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.02.012 · Cited by 161
“turns human CYP17A1 from a 17α-hydroxylase into a 17,20-lyase in steroid biosynthesis [31]; (iv) some genetic defects in human CPR would cause not only changes in drug metabolism but also the severe Antley–Bixler syndrome [32]; and (v) Fdx1 from S.”
BackgroundHomma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2460 · Cited by 153
Self-citationFukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155
Novel Associations in Disorders of Sex Development: Findings From the I-DSD Registry
Cox, K., Bryce, J., Jiang, J., Rodie, M., Sinnott, R., Alkhawari, M., Arlt, W., Audí, L., Balsamo, A., Bertelloni, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2918 · Cited by 156
Self-citationNADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology
Riddick, D. S., Ding, X., Wolf, C. R., Porter, T. D., Pandey, A. V., Zhang, Q., Gu, J., Finn, R. D., Ronseaux, S., McLaughlin, L. A., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048991 · Cited by 164
“By contrast, POR mutants A287P, C569Y, and V608F had variable effects on CYP19A1 and CYP17A1 activities (Table 1).”
BackgroundMethodInfluentialSelf-citationSteroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Self-citationMansouri, M. R., Schuster, J., Badhai, J., Stattin, E.-L., Lösel, R., Wehling, M., Carlsson, B., Hovatta, O., Karlstrom, P. O., Golovleva, I., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn274 · Cited by 140
“It has also been shown that mutations in the cytochrome P450 regulatory enzyme NADPH cytochrome P450 oxidoreductase, which is an electron donor involved in the catalytic activity of cytochrome P450 enzymes, cause Antley-Bixler syndrome characterized by the accumulation of steroid metabolites, adrenal hyperplasia and a…”
BackgroundMECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 145
Self-citationModulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132
Self-citationCongenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Genetic advances in craniosynostosis
Lattanzi, W., Barba, M., Di Pietro, L., & Boyadjiev, S. A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38159 · Cited by 129
“In addition, an autosomal recessive phenotype resembling that of Antley–Bixler syndrome, associated with coronal CS plus genital anomalies due to steroid biogenesis defects, is caused by cytochrome P450 oxidoreductase (POR) mutations (Flück et al., 2004).”
BackgroundLeuenberger, N., Pradervand, S., & Wahli, W. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39019 · Cited by 136
Gomes, A. M., Winter, S., Klein, K., Turpeinen, M., Schaeffeler, E., Schwab, M. G., & Zanger, U. M. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.7 · Cited by 138
Lajeunie, E., Heuertz, S., Ghouzzi, V. E., Martinovic, J., Rénier, D., Merrer, M. F. L., & Bonaventure, J. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201558 · Cited by 145
Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117
“Because the microdeletion was found in case 21 with apparent R457H homozygosity, such a microdeletion might be hidden in the previously reported patients with apparent homozygosity (1, 5).”
BackgroundSelf-citationAgrawal, V., Huang, N., & Miller, W. L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830054ac · Cited by 117
Self-citationNADPH–cytochrome P450 oxidoreductase: Prototypic member of the diflavin reductase family
Iyanagi, T., Xia, C., & Kim, J. J. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.002 · Cited by 134
Genetic and clinical features of P450 oxidoreductase deficiency
Scott, R. R., & Miller, W. L. (2008) · Hormone Research in Paediatrics · doi:10.1159/000114857 · Cited by 115
“and the recently described P450 oxidoreductase (POR) deficiency [”
BackgroundSelf-citationStructural basis for human NADPH-cytochrome P450 oxidoreductase deficiency
Xia, C., Panda, S. P., Marohnic, C. C., Pavel Martasek, E., Masters, B. S. S., & Kim, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106632108 · Cited by 118
“The authors concluded that deleterious POR mutations could account for decreased lanosterol demethylase (CYP51) activity previously observed in ABS patients and were sufficient to cause the ABS phenotype in the absence of fibroblast growth factor receptor type 2 mutations (3, 4, 9).”
InfluentialInborn Errors of Cholesterol Biosynthesis
Haas, D., & Kelley, R. I. (2006) · Springer eBooks · doi:10.1007/3-540-28962-3_32 · Cited by 115
Fukami, M., Homma, K., Hasegawa, T., & Ogata, T. (2013) · Developmental Dynamics · doi:10.1002/dvdy.23892 · Cited by 114
“3) (Arlt et al., 2004; Flück et al., 2004).”
Steroidogenesis of the testis – new genes and pathways
Flück, C. E., & Pandey, A. V. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.03.002 · Cited by 120
Self-citationDefects of cholesterol biosynthesis
Waterham, H. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.027 · Cited by 108
“mutations in the POR gene encoding cytochrome P450 oxidoreductase [21].”
BackgroundPlasticity of specialized metabolism as mediated by dynamic metabolons
Laursen, T., Møller, B. L., & Bassard, J.-É. (2014) · Trends in Plant Science · doi:10.1016/j.tplants.2014.11.002 · Cited by 118
Clinical dividends from the molecular genetic diagnosis of craniosynostosis
Wilkie, A. O. M., Bochukova, E. G., Hansen, R. M. S., Taylor, I. B., Rannan‐Eliya, S. V., Byren, J. C., Wall, S. A., Ramos, L. M., Venâncio, M., Hurst, J. A., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31366 · Cited by 109
Coccidioidomycosis During Pregnancy: A Review and Recommendations for Management
Bercovitch, R. S., Catanzaro, A., Schwartz, B. S., Pappagianis, D., Watts, D. H., & Ampel, N. M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir410 · Cited by 111
“Flück et al [63] have suggested that, in some women with POR”
Formation of P450·P450 complexes and their effect on P450 function
Reed, J. R., & Backes, W. L. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.009 · Cited by 105
“…ambiguous genitalia, and AntleyBixler syndrome have been identified as phenotypes resulting from mutations in the CPR gene that are caused by the impaired abilities of the mutant CPRs to interact with and/or deliver electrons to P450 (Flück et al., 2004; Huang et al., 2005; Xia et al., 2011).”
BackgroundPrenatal exposure to fluconazole: An identifiable dysmorphic phenotype
Lopez‐Rangel, E., & Allen, M. I. V. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20189 · Cited by 110
“, 2002) and P450 oxidoreductase (POR), mutations (Adachi et al., 2004; Fluck et al., 2004).”
BackgroundShackleton, C., Marcos, J., Arlt, W., & Hauffa, B. P. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30171 · Cited by 104
“Recent studies [Arlt et al., 2004; Fluck et al., 2004; Adachi et al., 2004b] have shown that APHD is a result of ORD.”
ResultSelf-citationIdkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Agrawal, V., Choi, J. H., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833e0cb5 · Cited by 108
Self-citationMarsh, C. A., & Auchus, R. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.011 · Cited by 103
Are azole fungicides a teratogenic risk for human conceptus?
Giavini, E., & Menegola, E. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.07.005 · Cited by 122
Keber, R., Motaln, H., Wagner, K. D., Debeljak, N., Rassoulzadegan, M., Ačimovič, J., Rozman, D., & Horvat, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253245 · Cited by 102
Hart, S. N., Wang, S., Nakamoto, K., Wesselman, C., Li, Y., & Zhong, X.-B. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f2f121 · Cited by 99
Hershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
“The diagnosis of POR deficiency was initially missed in these patients because the disorder was not characterized until 2004 (17) and because of the borderline nature of serum hormone values and the lack of the dysmorphic features of Antley-Bixler syndrome.”
BackgroundSelf-citationPharmacogenomics of human P450 oxidoreductase
Pandey, A. V., & Sproll, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00103 · Cited by 92
“…POR mutations in patients and identification several variants of POR in healthy individuals we suggested that POR variants may also impact drug metabolizing P450 enzymes since POR is necessary for activities of all microsomal P450 (Flück et al., 2004, 2007; Pandey et al., 2004; Huang et al., 2005).”
BackgroundInfluentialSelf-citationCongenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol
Miller, W. L. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501396 · Cited by 93
Self-citation3β-Hydroxysterol Δ7-reductase and the Smith–Lemli–Opitz syndrome
Correa-Cerro, L. S., & Porter, F. D. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.017 · Cited by 92
Genetic basis of potential therapeutic strategies for craniosynostosis
Melville, H., Wang, Y., Taub, P. J., & Jabs, E. W. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33703 · Cited by 93
Self-citationWhat Does AMH Tell Us in Pediatric Disorders of Sex Development?
Josso, N., & Rey, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00619 · Cited by 93
“P450 oxido-reductase (POR) serves as an electron donor for all microsomal cytochrome P450 enzymes (50).”
BackgroundGenetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Clinical dividends from the molecular genetic diagnosis of craniosynostosis†
Wilkie, A. O. M., Bochukova, E. G., Hansen, R. M. S., Taylor, I. B., Rannan‐Eliya, S. V., Byren, J. C., Wall, S. A., Ramos, L. M., Venâncio, M., Hurst, J. A., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31905 · Cited by 97
“The major discoveries that post-date these reviews have been of POR mutations in Antley– Bixler syndrome [Arlt et al., 2004; Flück et al., 2004] and of EFNB1 mutations in craniofrontonasal syndrome [Twigg et al.”
BackgroundClinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Self-citationMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Self-citationFukami, M., Hasegawa, T., Horikawa, R., Ohashi, T., Nishimura, G., Homma, K., & Ogata, T. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000195825.31504.28 · Cited by 79
“Clinical features in cases one through three would primarily be compatible with R457H retaining some residual activity (1,2,6) Since phenotypic severity is known to roughly correlate with residual POR activity (6), this would explain the absent or mild nondiagnostic skeletal lesion in cases one through three, the lack…”
BackgroundResultInfluentialP450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79
“Both C569Y and V608F caused a greater reduction in the activity of CYP19A1 compared to their effects on activities of CYP17A1 [6,12,14].”
BackgroundResultInfluentialSelf-citationScott, R. R., Gomes, L. G., Huang, N., Van Vliet, G., & Miller, W. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2345 · Cited by 79
Self-citationTomalik-Scharte, D., Maiter, D., Kirchheiner, J., Ivison, H. E., Fuhr, U., & Arlt, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0764 · Cited by 77
Differential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P
Dhir, V., Ivison, H. E., Krone, N., Shackleton, C. H. L., Doherty, A. J., Stewart, P. M., & Arlt, W. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0066 · Cited by 78
Self-citationFlück, C. E. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0128 · Cited by 75
Self-citationShackleton, C., Pozo, O. J., & Marcos, J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00135 · Cited by 75
46,XY DSD due to impaired androgen production
Mendonca, B. B., Costa, E. M. F., Belgorosky, A., Rivarola, M. A., & Domenice, S. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.003 · Cited by 78
Miller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 82
Self-citationEffects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
Sandee, D., Morrissey, K., Agrawal, V., Tam, H. K., Kramer, M. A., Tracy, T. S., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833f4f9b · Cited by 74
Self-citationBiased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase
Jensen, S. B., Thodberg, S., Parween, S., Moses, M. E., Hansen, C. C., Thomsen, J., Sletfjerding, M. B., Knudsen, C., Del Giudice, R., Lund, P. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22562-w · Cited by 64
Self-citationAlternative pathway androgen biosynthesis and human fetal female virilization
Reisch, N., Taylor, A. E., Nogueira, E. F., Asby, D. J., Dhir, V., Berry, A., Krone, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906623116 · Cited by 70
“POR-deficient neonates harbored the A287P mutation, which in the homozygous state is associated with normal male genitalia in boys and genital virilization (46,XXDSD).”
InfluentialSelf-citationBioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
Castaño, P. R., Parween, S., & Pandey, A. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184606 · Cited by 92
“Androgens regulate sexual differentiation in both the female as well as male and disruption of androgen biosynthesis by mutations in steroid metabolizing enzymes, or their redox partners, cause metabolic disorders [60].”
BackgroundSelf-citationTiosano, D., Knopf, C. F., Koren, I., Levanon, N., Hartmann, M. F., Hochberg, Z., & Wudy, S. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0712 · Cited by 73
Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action
Chan, L. F., Clark, A. J. L., & Metherell, L. (2007) · Hormone Research in Paediatrics · doi:10.1159/000111810 · Cited by 79
“P450 oxidoreductase deficiency in Antley-Bixler syndrome [”
The next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 73
Voss, S. R., Palumbo, A., Nagarajan, R., Gardiner, D. M., Muneoka, K., Stromberg, A. J., & Athippozhy, A. (2015) · Regeneration · doi:10.1002/reg2.37 · Cited by 72
“…, ldlr , lss , mvk , sc4mol , sc5dl , sqle ) that Schmidt et al. (2009) identified as differently expressed in response to conditional knockout of por in mice, a cytochrome P450 that is essential for steroidogenesis (Fl¨uck et al. 2004), were coordinately upregulated in our study at 22 − 24 DPA.”
Wu, L., Gu, J., Cui, H., Zhang, Q.-Y., Behr, M. J., Fang, C., Weng, Y., Kluetzman, K., Swiatek, P. J., Yang, W., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073353 · Cited by 67
“However, several functionally significant single-nucleotide polymorphisms were identified in a recent study in which CPR mutations were associated with disordered steroidogenesis (Flück et al., 2004).”
BackgroundPrenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency
Reisch, N., Idkowiak, J., Hughes, B. A., Ivison, H. E., Abdul-Rahman, O. A., Hendon, L. G., Olney, A. H., Nielsen, S., Harrison, R., Blair, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3449 · Cited by 67
Self-citationConsequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
“First, there is partial deficiency placental aromatase (P450aro) activity in some, but not all, pregnancies (Fluck et al., 2004; Huang et al., 2005), resulting in fetal virilization similar to that seen with P450aro deficiency.”
BackgroundMethodInfluentialSelf-citationHorvat, S., McWhir, J., & Rozman, D. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.540580 · Cited by 73
“It was later revealed that the cause of the abnormal sterol profile and genital malformations lies in mutations of the POR gene (Fluck et al., 2004).”
Background
Metadata
- Authors
- Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Hokkaido University (JP)
- Sydney Children's Hospital (AU)
- Johns Hopkins University (US)
- Asahikawa Medical University (JP)
- Corresponding author
- Miller, Walter L
- Venue
- Nature Genetics
- Published
- 2004-02-01
- Volume
- 36
- Issue
- 3
- Pages
- 228-230
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1988067304
- Semantic Scholar
- de46a6781c9fe47ed0dcc705d3a243d3ba41bef5
- Cited by
- 509
- References
- 14
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 16 · 2023: 15 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 15 · 2017: 24 · 2016: 22 · 2015: 24 · 2014: 19 · 2013: 28 · 2012: 21
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- National Research Foundation
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- Antley-Bixler syndrome, cytochrome P450 oxidoreductase, POR gene, steroidogenesis disorders, amenorrhea, fluconazole, drug metabolism, congenital disorders of sex development
- MeSH terms
- Craniosynostoses, Female, Humans, Ketone Oxidoreductases, Mutation, NADPH-Ferrihemoprotein Reductase, Gonadal Steroid Hormones, Syndrome, Synostosis, Pyruvate Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.